Market Analysis - Natural Products 2017
Natural products play an important role in drug discovery. About more than 50 percent of FDA-approved drugs were Natural products or Medicinal Plants derivatives.For thousands of year’s natural products have played a very important role in health care and prevention of diseases. It is estimated that about 70% of the supply of herbal raw material for Ayurveda and other homeopathic medicines in India comes from the wild. To meet the increasing demand for raw material, to conserve wild resources, and to reduce the potential variability in the active ingredient content in medicinal plants from different collection areas, it is important to implement more controlled cultivation programs to ensure quality and to protect resources. The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.
Natural products sometimes have pharmacological or biological activity that can be of therapeutic benefit in treating diseases. As such, natural products are the active components not only of most traditional medicines but also many modern medicines. Furthermore, because the structural diversity of natural products exceeds that readily achievable by chemical synthesis, and synthetic analogs can be prepared with improved potency and safety, natural products are often used as starting points for drug discovery. In fact, natural products are the inspiration for approximately one half of U.S. Food and Drug Administration-approved drugs.
A variety of retail stores sell natural products in the United States with over 3,000 natural food vendors. One of the most popular is the Whole Foods Market chain which began in 1980 with one store and now has over 300 stores in North America and the United Kingdom. It is important to realize that Whole Foods Markets does the majority of its buying through a large natural products distributor called UNFI. UNFI is the leading independent US distributor of natural, organic and speciality foods and related products (which includes dietary supplements and natural cosmetics). Other natural products, such as cosmetics and organic clothing, can be found in a variety of stores and superstores. These generally buy via distributors with only a minority going directly to producers. Fair trade stores throughout North America focus their buying on members of the Fair Trade Federation or the World Fair Trade Organization. It is also important to realize that some of the leading cosmetic and dietary supplement consumer products in the United States market are actually manufactured in Europe. These European natural products are relabelled for the United States market and distributed either by the foreign company’s United States sales and marketing division, through a subsidiary or by a company that has obtained exclusive sales and marketing rights in the United States.
Global Market Analysis for Marine Drugs and Natural Products
In 2010, according to the Nutrition Business Journal, sales of natural products grew 6 percent to $117 billion. Below are additional statistics from 2010 regarding natural products:
- Natural/organic food items totalled $39 billion, an 8.3 percent increase from 2009.
- Functional foods made up over one-third of the entire natural products market share, at $39 billion.
- Supplement sales in natural product stores were up 4.4 percent to $28 billion.
- Natural products consumers are often motivated not only by their own health, but making buying choices that lead to sustainability of the environment.
Global Market Analysis of Marine derived pharmaceuticals
The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016. Europe region appears us the second largest market in Marine Biotechnology across the globe. The research and development activities and the infrastructure support to the marine is the main reason for the growth of Marine Biotechnology in Europe. There is a huge rapid technology growth working offshore in deeper water. The offshore renewable energy installation provides further more growth in Biotechnology. The sea and coasts that deliver basic human resources such as food and energy also play an important role in the growth of this technology. The offshore renewable energy installation
Global Market Analysis of Botanical and Plant-derived Drugs
The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.
The global botanical and plant derived drug market is expected to grow at the CAGR of 6.8% during 2015-2022. Botanical and plant derived drug market has wide applications in medical field. Rising prevalence of chronic diseases has made a significant impact in the growth of botanical and plant derived drug market. Plant derived drug are comparatively low in price as compared to other chemical derived drugs. Improved sociological and technological advancements are the key factors that are driving the growth of this market. Moreover, increasing number of FDA approvals for botanical and plant derived drugs and their applications are acting as an opportunity for the growth of plant derived drugs market. Although there are many factors driving the market yet there are some challenges faced by the market such as availability of alternatives and lack of awareness related to advantages of botanical and plant derived drugs.
Based on geography the market is segmented into North America, Europe, APAC, Middle East & Africa and Latin America. Europe & North America dominates the global botanical and plant derived drug owing to increasing awareness of medicinal plants and plant derived drugs and rising prevalence of diseases. Asia Pacific is anticipated to grow significantly over the forecasted period owing to advancements in medical industry in the region. India and China are anticipated to witness significant growth rate due to growing population in the region and rising prevalence of chronic diseases.
Market Analysis of Dietary supplements
The United States retail sales of dietary supplements exceeded US$ 9 billion in 2009, up 8% from 2008. From 2005 to 2009 the market grew by a total of 26%. In Canada, the supplement retail industry was expected to exceed Can$ 2.75 billion in value by the end of 2010. Today, although the dietary supplement markets remains strong, its growth, while steady, has slowed considerably. The global market for OTC medicines and dietary supplements reached $128.8 billion in 2012. This market is expected to reach to $142.7 billion in 2013 and $189.7 billion in 2018, with a compound annual growth rate (CAGR) of 5.9%.
The analysts forecast global herbal supplements market to grow at a CAGR of 6.29% during the period 2016-2020. According to the 2016 herbal supplements market report, one driver facilitating growth is the growing awareness about benefits of dietary supplements. To fill the gap in nutritional requirements consumers are opting for functional foods such as supplements in the form of powder, syrup, or tablets in their daily diet to minimize the chances of developing health complications and remain healthy and fit.
The demand for herbal supplements is stimulated by an increase in healthcare expenses across the globe. Rise in prices of drugs, medical devices, and hospital care are the some of the factors triggering the rise in healthcare cost. In 2015, the global herbal supplements market was dominated by Europe with a market share of around 45%. Growing e-commerce and number of retail stores coupled with a rise in the older population is expected to boost growth in the herbal supplements market in Europe during the forecast period. During 2015, the retail store segment dominated the global herbal supplements market by accounting for a market share of more than 52% in terms of revenue.
Market Analysis of Natural Cosmetic Products
The Global Organic Personal Care market is estimated at $10.64 billion in 2015 and is expected to grow at a CAGR of 9.6% to reach $19.83 billion by 2022. Increasing customer awareness about personal hygiene is expected to support the market growth over the forecast period. Personal care products market is observing paradigm move from artificial to organic personal care products. Organic skin care products dominated the global demand, and the segment generated revenue exceeding USD 2.5 billion in 2013. Rising importance of natural ingredients such as herbs, vegetables, and fruits in skin care products with anti-ageing properties is expected to fuel demand.
Organic hair care products are expected to grow at a CAGR of 9.6% from 2014 to 2020. Organic oral care accounted for 13% of the global revenue in 2013. Use of natural ingredients in the formulation of oral care products helps protect against gum disease, periodontal disease, and bleeding gums. In line with the same, companies such as Colgate-Palmolive and Hindustan Unilever have incorporated herbal substances such as neem and clove in their product offerings.New product formulations and demand for herbal & organic ingredients in cosmetics is expected to drive the regional market over the forecast period. Rising economic standards and growing awareness about personal grooming and hygiene are also anticipated to boost the cosmetics market growths which, in turn, have a positive impact on the global Cosmetic Preservative Market.
Europe is expected to be the second largest market leading market for natural and organic personal care product in terms of demand.Europe market to register high growth in the organic cosmetic preservatives market by 2020. Europe organic personal care market size exceeded USD 2,400 million in 2013 Increasing preference towards naturally derived personal care products over synthetic counterparts in Europe is expected to have a favourable impact on the industry over the forecast period. Furthermore, supporting regulatory framework for the use of naturally-derived products is expected to propel growth in the region over the forecast period.
Funding for Natural Products Research
The US National Institutes of Health (NIH) has awarded nearly $35 million (£22.7 million) to fund research into botanical dietary supplements and other natural products, which include various substances produced by plants, bacteria, fungi, and animals historically used in traditional medicine and other complementary and integrative health practices. The agency announced that it will fund five research centres to examine the safety of such natural products, study how they work within the body, and develop cutting-edge research technologies to probe such substances.
Specifically, the NIH expects to provide competitive grant awards worth $2 million annually for five years to the three botanical dietary supplements research centres, and the agency anticipates awarding two natural products innovation centres a combined budget of $1.25 million per year for five years. They are expected to develop new research approaches and technologies that will have significant impact on the chemical and biological investigation of natural products. They will also provide leadership in coordinating scientific discourse and disseminating innovative methodology and good research practices to the research community on natural products. Many of the supplements that the centres plan to study with the NIH funding including black cohosh, fenugreek, licorice, and valerian are among the top 100 supplements consumed in the US, according to the NIH. The agency points to survey data indicating that nearly one in five adults in America use botanical supplements and other non-vitamin, non-mineral dietary supplements like omega-3 fatty acids and probiotics.
Conference Series LLC organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members.
Conference Series LLC invites all the participants across the globe to attend the ‘’2nd International Conference and Exhibition on Marine Drugs and Natural Products” Marine Drugs and Natural Products conveys recent discoveries and developments in Marine drugs discovery and natural produced drugs. A complete knowledge of a scientific discipline that described the Marine drug discovery and development and Marine Drugs and Natural Products now explores the use of Natural products in industry as well as healthcare.
Marine Drugs and Natural Products 2017 is the chemistry of marine organisms is relatively unexplored and represents a vast resource for new medicines to combat major diseases such as cancer, AIDS or malaria. Research typically focuses on sessile organisms or slow moving animals because of their inherent need for chemical defenses. Standard research involves an extraction of the organism in a suitable solvent followed by either an assay of this crude extract for a particular disease target or a rationally guided isolation of new chemical compounds using standard chromatography techniques.
Moreover, it is likely that for every compound that does make it to the market, a better drug with distinct chemistry, improved bioavailability and less unwanted side effects can be found either in chemical libraries or among the much larger number and diversity of natural products.
In recent years, marine natural product bioprospecting has yielded a considerable number of drug candidates. Most of these molecules are still in preclinical or early clinical development but some are already on the market, such as cytarabine, or are predicted to be approved soon, such as ET743 (YondelisTM). Research into the ecology of marine natural products has shown that many of these compounds function as chemical weapons and have evolved into highly potent inhibitors of physiological processes in the prey, predators or competitors of the marine organisms that use them. Some of the natural products isolated from marine invertebrates have been shown to be, or are suspected to be, of microbial origin and this is now thought to be the case for the majority of such molecules. Marine microorganisms, whose immense genetic and biochemical diversity is only beginning to be appreciated, look likely to become a rich source of novel chemical entities for the discovery of more effective drugs.